ABWM
BIIB icon

Alpine Bank Wealth Management’s Biogen BIIB Stock Holding History

Alpine Bank Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$118K Buy
+545
New +$104K 0.02% 204
2025
Q4 		– Sell
-545
Closed -$76.3K – 173
2025
Q3 		$76.3K Hold
545
– – 0.01% 214
2025
Q2 		$68.4K Sell
545
-350
-39% -$43.6K 0.01% 221
2025
Q1 		$122K Buy
+895
New +$128K 0.02% 166
2024
Q3 		$194K Buy
+1,003
New +$210K 0.03% 148

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Alpine Bank Wealth Management's BIIB Position: Q2 2026 in Review

Alpine Bank Wealth Management opened a new position in Biogen (BIIB) in Q2 2026: 545 shares worth $118K. The stake represents 0.02% of the portfolio and ranks #204 among its holdings. This is a return to the name: Alpine Bank Wealth Management previously reported a position in BIIB as recently as Q3 2025.

Alpine Bank Wealth Management first reported a position in BIIB in Q3 2024 and has held it in 5 quarters since. The position peaked at $194K in Q3 2024. 575 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Alpine Bank Wealth Management held 545 shares of Biogen worth $118K as of Q2 2026.
  • Biogen was a new Alpine Bank Wealth Management position in Q2 2026.
  • Biogen made up 0.02% of Alpine Bank Wealth Management's portfolio in Q2 2026, its #204 holding.
  • Alpine Bank Wealth Management first reported a position in Biogen in Q3 2024 and has held it in 5 quarters since.
  • Alpine Bank Wealth Management's Biogen position peaked at $194K in Q3 2024.
  • 575 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Alpine Bank Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.